EMA Panel Backs Peanut Allergy Desensitizing Powder Palforzia EMA Panel Backs Peanut Allergy Desensitizing Powder Palforzia

The powder will be the first treatment option in the European Union for patients with peanut allergy. The FDA approved the treatment in January.International Approvals
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Alert Source Type: news